Aignosis
PrivateLast Round
Seed
Oct 1, 2026
Est. Valuation
$1.5M
Total Funding Raised
$559,560
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Aignosis operates in Healthcare & Life Sciences and is based in Jaipur. Its latest recorded funding round was a Seed round in October 2026.
Aignosis is a healthcare technology company that offers an AI-based platform for early autism screening and detection.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Healthcare Analytics, Computer Vision
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aignosis Comparables
Compare Aignosis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DeepTek | 74% | |
| Tempus | 72% | |
| Ibex Medical Analytics | 71% |
For institutional investors. Book with your work email.
Aignosis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 1, 2026 | ||||
| Grant | Feb 13, 2025 | ||||
| Angel | Jan 24, 2025 |
For institutional investors. Book with your work email.
Aignosis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Antler | Seed |
| Startup Oasis | Seed |
| WTFund | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2026
$416K raised in Seed round.
- Aug 21, 2026
Monthly visitors grew 495% MoM, reaching 7.2K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withOct 1, 2026
Aignosis Artificial Intelligence Private Limited partners with Mankind Pharma, whose nearly 1,300 medical representatives support screening camps with paediatricians across India.
- receives_financingOct 1, 2026
Aignosis Artificial Intelligence Private Limited raised $417K in Seed financing in India in a round led by Antler, with Nikhil Kamath, Varun Dua and IIMA Ventures among the participating investors.
- expands_offices_inOct 1, 2026
Aignosis Artificial Intelligence Private Limited is expanding its AI-assisted screening model across India through government health centres, clinics, screening camps and schools, with plans to enter Punjab, NCR, Haryana, Tamil Nadu, Jharkhand, Karnataka and Maharashtra.
For institutional investors. Book with your work email.
Aignosis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aignosis's valuation, stock price, and market status.
Is Aignosis a public or private company?
Aignosis is a private company.
What is the current stock price of Aignosis?
Aignosis is a private company, so its shares have no public market price. Caplight tracks Aignosis's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aignosis worth (valuation)?
Aignosis's valuation is estimated at $1.5M based on funding round data.
Can I buy Aignosis stock?
Aignosis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aignosis's last funding round?
Aignosis's most recent funding round was Seed on October 1, 2026.
Who are the main investors in Aignosis?
Key investors in Aignosis include Antler.
Will Aignosis IPO soon?
No public IPO plans have been announced for Aignosis.
How can I track Aignosis secondary market activity?
Caplight tracks bids, offers, and trades in Aignosis's shares on secondary markets.